mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity

Published:2015-08 Issue:8 Volume:23 Page:1391-1400
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Cafri Gal,Sharbi-Yunger Adi,Tzehoval Esther,Alteber Zoya,Gross Tamar,Vadai Ezra,Margalit Alon,Gross Gideon,Eisenbach Lea

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference40 articles.

1. Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells;Hegmans;Am J Respir Crit Care Med,2005

2. Immunotherapy with autologous dendritic cells and tumor-specific synthetic peptides for synovial sarcoma;Matsuzaki;J Pediatr Hematol Oncol,2002

3. Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies;Ritchie;Leuk Lymphoma,2006

4. Induction of peptide-specific immune response in patients with primary malignant melanoma of the esophagus after immunotherapy using dendritic cells pulsed with MAGE peptides;Ueda;Jpn J Clin Oncol,2007

5. Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity;Isomura;Microbiol Immunol,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity;eLife;2024-06-17

2. Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity;2024-04-29

3. Expression of modified Fc γ RI enables myeloid cells to elicit robust tumor-specific cytotoxicity;ELIFE;2023-12-27

4. The main battlefield of mRNA vaccine – Tumor immune microenvironment;International Immunopharmacology;2022-12

5. Virus‐Mimic mRNA Vaccine for Cancer Treatment;Advanced Therapeutics;2021-09-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3